Tomomi Fujii

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Topics

Bacillus Subtilis

Cell Proliferation

Muscle Invasive Bladder Cancer

Magnetic Resonance Imaging

Top Venues

Pathology international

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Makito Miyake, Nobutaka Nishimura, Sayuri Ohnishi, Yuki Oda, Takuya Owari, Kenta Ohnishi, Yosuke Morizawa, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer. Cancers 15 (9) (2023)
Makito Miyake, Nobutaka Nishimura, Sayuri Ohnishi, Yuki Oda, Takuya Owari, Kenta Ohnishi, Yosuke Morizawa, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer. Cancers 15 (9) (2023)
Makito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Kiyohide Fujimoto
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent. Case reports in urology 2023 (2023)
Makito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Kiyohide Fujimoto
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent. Case reports in urology 2023 (2023)
Tomomi Fujii, Maiko Takeda, Tomoko Uchiyama, Yuji Nitta, Katsuya Maebou, Chiyoko Terada, Fumi Okada, Minami Matsuoka, Sumire Sugimoto, Shoh Sasaki, Kohei Morita, Hiroe Itami, Makito Miyake, Masayuki Takeda, Noriyoshi Sawabata, Kiyohide Fujimoto, Chiho Ohbayashi
Identification of fusion transcripts in sarcoma from archival formalin-fixed paraffin-embedded tissues: A next-generation sequencing approach. Pathology international 72 (9) (2022)
Naoko Takeda-Miyata, Aya Miyagawa-Hayashino, Shinshichi Hamada, Michiko Nagamine, Tomomi Fujii, Tetsuya Imura, Hiroaki Tsunezuka, Masanori Shimomura, Tadanori Yamaguchi, Masashi Yanada, Masayoshi Inoue, Eiichi Konishi
A clinicopathologic and molecular analysis of five cases of bronchiolar adenoma with rare mutations. Pathology international 72 (5) (2022)
Makito Miyake, Yuki Oda, Takuya Owari, Kota Iida, Sayuri Ohnishi, Tomomi Fujii, Nobutaka Nishimura, Tatsuki Miyamoto, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer. Cancer science (2022)
Shigenobu Tatsumi, Mao Takeuchi, Tomomi Fujii, Aya Sugimoto, Yoko Sekita-Hatakeyama, Takeshi Nishikawa, Tomoko Uchiyama, Kohei Morita, Hiroe Itami, Maiko Takeda, Masaharu Yamazaki, Chiho Ohbayashi
Evaluation of DNA/RNA quality from cell block of malignant mesothelioma and lung adenocarcinoma. Diagnostic cytopathology 50 (6) (2022)
Makito Miyake, Nobutaka Nishimura, Kota Iida, Tomomi Fujii, Ryoma Nishikawa, Shogo Teraoka, Atsushi Takenaka, Hiroshi Kikuchi, Takashige Abe, Nobuo Shinohara, Eijiro Okajima, Takuto Shimizu, Shunta Hori, Norihiko Tsuchiya, Takuya Owari, Yasukiyo Murakami, Rikiya Taoka, Takashi Kobayashi, Takahiro Kojima, Naotaka Nishiyama, Hiroshi Kitamura, Hiroyuki Nishiyama, Kiyohide Fujimoto
Intravesical Bacillus Calmette-Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies. Cancers 13 (11) (2021)
Makito Miyake, Nobutaka Nishimura, Yasushi Nakai, Tomomi Fujii, Takuya Owari, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Yoshihiko Hirao, Kiyohide Fujimoto
Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method. Diagnostics (Basel, Switzerland) 11 (2) (2021)
Hiroe Itami, Kohei Morita, Tokiko Nakai, Tomoko Uchiyama, Sumire Sugimoto, Shoh Sasaki, Minami Matsuoka, Tomoya Myojin, Yuji Nitta, Fumi Okabe, Tomomi Fujii, Kinta Hatakeyama, Akira Mitoro, Masayuki Sho, Chiho Ohbayashi
Gastritis cystica profunda is associated with aberrant p53 and Epstein-Barr virus in gastric cancer: A clinicopathological, immunohistochemical and in situ hybridization study. Pathology international 71 (1) (2020)
Makito Miyake, Shunta Hori, Takuya Owari, Yuki Oda, Yoshihiro Tatsumi, Yasushi Nakai, Tomomi Fujii, Kiyohide Fujimoto
Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma. Cancers 12 (11) (2020)
Tomomi Fujii, Tomoko Uchiyama, Minami Matsuoka, Tomoya Myojin, Sumire Sugimoto, Yuji Nitta, Fumi Okabe, Aya Sugimoto, Yoko Sekita-Hatakeyama, Kohei Morita, Hiroe Itami, Kinta Hatakeyama, Chiho Ohbayashi
Evaluation of DNA and RNA quality from archival formalin-fixed paraffin-embedded tissue for next-generation sequencing - Retrospective study in Japanese single institution. Pathology international 70 (9) (2020)
Makito Miyake, Shunta Hori, Yoshitaka Itami, Yuki Oda, Takuya Owari, Tomomi Fujii, Sayuri Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model. Cancers 12 (7) (2020)
Makito Miyake, Fumisato Maesaka, Nagaaki Marugami, Tatsuki Miyamoto, Yasushi Nakai, Sayuri Ohnishi, Daisuke Gotoh, Takuya Owari, Shunta Hori, Yosuke Morizawa, Yoshitaka Itami, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Tomomi Fujii, Keiji Shimada, Nobumichi Tanaka, Kiyohide Fujimoto
A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'. Diagnostics (Basel, Switzerland) 9 (3) (2019)
Makito Miyake, Shunta Hori, Sayuri Ohnishi, Michihiro Toritsuka, Tomomi Fujii, Takuto Shimizu, Takuya Owari, Yosuke Morizawa, Daisuke Gotoh, Yoshitaka Itami, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Supplementary granulocyte macrophage colony-stimulating factor to chemotherapy and programmed death-ligand 1 blockade decreases local recurrence after surgery in bladder cancer. Cancer science 110 (10) (2019)
Makito Miyake, Kenta Ohnishi, Shunta Hori, Akiyo Nakano, Ryuichi Nakano, Hisakazu Yano, Sayuri Ohnishi, Takuya Owari, Yosuke Morizawa, Yoshitaka Itami, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Tomomi Fujii, Hideki Furuya, Charles J Rosser, Kiyohide Fujimoto
Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens. Cells 8 (3) (2019)
Makito Miyake, Shunta Hori, Sayuri Ohnishi, Takuya Owari, Kota Iida, Kenta Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yoshitaka Itami, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin. Diseases (Basel, Switzerland) 7 (2) (2019)
Tomomi Fujii, Keiji Shimada, Tokiko Nakai, Chiho Ohbayashi
MicroRNAs in Smoking-Related Carcinogenesis: Biomarkers, Functions, and Therapy. Journal of clinical medicine 7 (5) (2018)
Kohei Morita, Tomomi Fujii, Hiroe Itami, Tomoko Uchiyama, Tokiko Nakai, Kinta Hatakeyama, Aya Sugimoto, Makito Miyake, Yasushi Nakai, Nobumichi Tanaka, Keiji Shimada, Masaharu Yamazaki, Kiyohide Fujimoto, Chiho Ohbayashi
NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells. Cancers 10 (10) (2018)